Mativ Holdings (MATV) Stock

Mativ Holdings, Inc. (NYSE:MATV ) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET Company Participants Julie Schertell - Chief Executive Officer Greg Weitzel - Chief Financial Officer Chris Kuepper - Director of Investor Relations Conference Call Participants Daniel Harriman - Sidoti Jonathan Tanwanteng - CJS Securities Operator Welcome to the Mativ Third Quarter 2024 Earnings Conference Call. On the call today from Mativ are Julie Schertell, Chief Executive Officer; Greg Weitzel, Chief Financial Officer; and Chris Kuepper, Director, Investor Relations.

ALPHARETTA, Ga,--(BUSINESS WIRE)--Mativ Holdings, Inc. ("Mativ" or the "Company") (NYSE: MATV) reported earnings results for the three months ended September 30, 2024. On November 30, 2023, Mativ Holdings, Inc. (“Mativ” or the “Company”) completed the sale of its Engineered Papers business. Financial results for continuing operations exclude Engineered Papers in all periods. Adjusted measures are reconciled to GAAP at the end of this release. Financial comparisons are versus the prior year peri.

ALPHARETTA, Ga.--(BUSINESS WIRE)--Mativ Holdings, Inc. (“Mativ” or the “Company”) (NYSE: MATV) today announced that it has priced its previously announced private offering of $400,000,000 in aggregate principal amount of its 8.000% senior notes due 2029 (the “Notes”). The Notes will bear interest at an annual rate of 8.000% and will be issued at a price equal to 100.000% of the principal amount thereof. The offering is expected to close on October 7, 2024, subject to customary closing condition.

Mativ Holdings (MATV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

ALPHARETTA, Ga.--(BUSINESS WIRE)--Mativ Holdings, Inc. (NYSE: MATV) today announced it has appointed John K. Stipancich as an independent member of its board of directors, effective June 13, 2024, for a term of office expiring at the 2027 annual meeting. In connection with his appointment, Stipancich has also been appointed to serve on the Board's audit committee. “We're pleased to welcome John to the Board. With over 30 years of experience, he brings a deep well of legal, operational, and fina.

Mativ Holdings, Inc. (NYSE: MATV) has announced that it will report its first quarter 2024 financial results on May 8, 2024, after the market closes. A conference call to review these results is set for 8:30 a.m. ET on May 9, 2024. The call can be joined via webcast or telephone. A replay of the call will be available on the Investors section of Mativ's website at ir.mativ.com following the webcast.

Investors interested in Chemical - Specialty stocks may want to consider Mativ Holdings (MATV) or Novozymes A/S (NVZMY). The question is, which of these two stocks provides better value for value investors currently?

Investors interested in Chemical - Specialty stocks are likely familiar with Mativ Holdings (MATV) and Novozymes A/S (NVZMY). But which of these two stocks offers value investors a better bang for their buck right now?

Investors interested in stocks from the Chemical - Specialty sector have probably already heard of Mativ Holdings (MATV) and Novozymes A/S (NVZMY). But which of these two stocks offers value investors a better bang for their buck right now?